Analysis scripts for HER2 benign-field NanoString and MxIF study

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: nicolecruzreyes, Nicole Cruz-Reyes, Stacey J. Winham, Derek C. Radisky
DOI: 10.5281/zenodo.18391854
Cited by: 0

Abstract

This repository contains R scripts used to generate the main and supplementary figuresfor a nested case–control benign breast disease (BBD) study examining immune and stromalfield effects associated with subsequent ipsilateral HER2-positive breast cancer. Analyses integrate NanoString bulk transcriptomics and multiplex immunofluorescence (MxIF)spatial metrics. No datasets are included; scripts expect local de-identified CSV inputs.

Fields of Study & Subjects

Breast Cancer Treatment Studies Breast Lesions and Carcinomas HER2/EGFR in Cancer Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 January 2026
Language
EN